Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model.

Chen IF, Ou-Yang F, Hung JY, Liu JC, Wang H, Wang SC, Hou MF, Hortobagyi GN, Hung MC.

Mol Cancer Ther. 2006 Jan;5(1):1-7.

2.
3.
4.

Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer.

Ding Y, Wang L, Su LK, Frey JA, Shao R, Hunt KK, Yan DH.

Oncogene. 2004 Jun 3;23(26):4556-66.

PMID:
15122330
6.

Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.

Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.

Cancer Chemother Pharmacol. 2009 Mar;63(4):673-80. doi: 10.1007/s00280-008-0784-9. Epub 2008 Jul 3.

PMID:
18597088
7.

Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.

Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A.

Mol Cancer Ther. 2007 Oct;6(10):2757-65. Epub 2007 Oct 3.

8.

Prostate-specific antitumor activity by probasin promoter-directed p202 expression.

Wen Y, Giri D, Yan DH, Spohn B, Zinner RG, Xia W, Thompson TC, Matusik RJ, Hung MC.

Mol Carcinog. 2003 Jul;37(3):130-7.

PMID:
12884364
9.

[Inhibitory effect of Adp53 and F56 on growth and metastasis of transplantation of the breast tumor in mice].

Xiao SW, Yan B, Yang JX, Shou CC, Zhang SW.

Beijing Da Xue Xue Bao. 2007 Apr 18;39(2):171-6. Chinese.

10.

Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.

Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S.

Clin Cancer Res. 2008 Apr 1;14(7):2128-36. doi: 10.1158/1078-0432.CCR-07-4722.

11.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
12.

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.

Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.

13.
14.

TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.

Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.

Exp Cell Res. 2008 Feb 1;314(3):509-29. Epub 2007 Oct 13.

PMID:
18061162
15.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
16.

Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.

Adam L, Black PC, Kassouf W, Eve B, McConkey D, Munsell MF, Benedict WF, Dinney CP.

J Urol. 2007 May;177(5):1900-6.

PMID:
17437845
17.

Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.

Wang WB, Zhou YL, Heng DF, Miao CH, Cao YL.

Breast Cancer Res Treat. 2008 Jul;110(2):283-95. Epub 2007 Sep 26.

PMID:
17899369
18.

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD.

Cancer Res. 2002 Sep 1;62(17):4854-9.

19.

Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2.

Cresswell KS, Clarke CJ, Jackson JT, Darcy PK, Trapani JA, Johnstone RW.

Biochem Biophys Res Commun. 2005 Jan 14;326(2):417-24.

PMID:
15582594
20.

p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.

Wen Y, Yan DH, Wang B, Spohn B, Ding Y, Shao R, Zou Y, Xie K, Hung MC.

Cancer Res. 2001 Oct 1;61(19):7142-7.

Items per page

Supplemental Content

Write to the Help Desk